Literature DB >> 26231208

Altered activation of protein kinase PKR and enhanced apoptosis in dystonia cells carrying a mutation in PKR activator protein PACT.

Lauren S Vaughn1, D Cristopher Bragg2, Nutan Sharma2, Sarah Camargos3, Francisco Cardoso3, Rekha C Patel4.   

Abstract

PACT is a stress-modulated activator of the interferon-induced double-stranded RNA-activated protein kinase (PKR). Stress-induced phosphorylation of PACT is essential for PACT's association with PKR leading to PKR activation. PKR activation leads to phosphorylation of translation initiation factor eIF2α inhibition of protein synthesis and apoptosis. A recessively inherited form of early-onset dystonia DYT16 has been recently identified to arise due to a homozygous missense mutation P222L in PACT. To examine if the mutant P222L protein alters the stress-response pathway, we examined the ability of mutant P222L to interact with and activate PKR. Our results indicate that the substitution mutant P222L activates PKR more robustly and for longer duration albeit with slower kinetics in response to the endoplasmic reticulum stress. In addition, the affinity of PACT-PACT and PACT-PKR interactions is enhanced in dystonia patient lymphoblasts, thereby leading to intensified PKR activation and enhanced cellular death. P222L mutation also changes the affinity of PACT-TRBP interaction after cellular stress, thereby offering a mechanism for the delayed PKR activation in response to stress. Our results demonstrate the impact of a dystonia-causing substitution mutation on stress-induced cellular apoptosis.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apoptosis; cell death; endoplasmic reticulum stress (ER stress); interferon; protein kinase RNA-activated (PKR)

Mesh:

Substances:

Year:  2015        PMID: 26231208      PMCID: PMC4566229          DOI: 10.1074/jbc.M115.669408

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Modular structure of PACT: distinct domains for binding and activating PKR.

Authors:  G A Peters; R Hartmann; J Qin; G C Sen
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  DYT16: a new twist to familial dystonia.

Authors:  Christine Klein
Journal:  Lancet Neurol       Date:  2008-02-01       Impact factor: 44.182

3.  A novel presentation of DYT 16: acute onset in infancy and association with MRI abnormalities.

Authors:  Monica E Lemmon; Bennett Lavenstein; Carolyn D Applegate; Ada Hamosh; Aylin Tekes; Harvey S Singer
Journal:  Mov Disord       Date:  2013-10-18       Impact factor: 10.338

4.  Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation.

Authors:  Madhurima Singh; David Castillo; Chandrashekhar V Patel; Rekha C Patel
Journal:  Biochemistry       Date:  2011-05-06       Impact factor: 3.162

Review 5.  The diagnosis of dystonia.

Authors:  Howard L Geyer; Susan B Bressman
Journal:  Lancet Neurol       Date:  2006-09       Impact factor: 44.182

6.  Use of cyclosporin A in establishing Epstein-Barr virus-transformed human lymphoblastoid cell lines.

Authors:  M A Anderson; J F Gusella
Journal:  In Vitro       Date:  1984-11

7.  Exploring the influence of torsinA expression on protein quality control.

Authors:  Kara L Gordon; Kevin A Glenn; Pedro Gonzalez-Alegre
Journal:  Neurochem Res       Date:  2010-12-16       Impact factor: 3.996

Review 8.  Molecular pathways in dystonia.

Authors:  D Cristopher Bragg; Ioanna A Armata; Flavia C Nery; Xandra O Breakefield; Nutan Sharma
Journal:  Neurobiol Dis       Date:  2010-12-04       Impact factor: 5.996

9.  RAX, the PKR activator, sensitizes cells to inflammatory cytokines, serum withdrawal, chemotherapy, and viral infection.

Authors:  Richard L Bennett; William L Blalock; Dean M Abtahi; Yu Pan; Sue A Moyer; W Stratford May
Journal:  Blood       Date:  2006-08-01       Impact factor: 22.113

10.  Essential role of PACT-mediated PKR activation in tunicamycin-induced apoptosis.

Authors:  Madhurima Singh; Vennece Fowlkes; Indhira Handy; Chandrashekhar V Patel; Rekha C Patel
Journal:  J Mol Biol       Date:  2008-11-05       Impact factor: 5.469

View more
  20 in total

1.  A novel antisense RNA ASPACT confers multi-level suppression of PACT and associated signalling.

Authors:  Yu-Ping Kuo; Chung-Pei Ma; Hui-Wen Chen; Yi-Tung Chen; Yi-Hsuan Lai; Hsuan Liu; Rei-Lin Kuo; Bertrand Chin-Ming Tan
Journal:  RNA Biol       Date:  2019-06-12       Impact factor: 4.652

Review 2.  Double-Stranded RNA Sensors and Modulators in Innate Immunity.

Authors:  Sun Hur
Journal:  Annu Rev Immunol       Date:  2019-01-23       Impact factor: 28.527

3.  Disruption of Protein Processing in the Endoplasmic Reticulum of DYT1 Knock-in Mice Implicates Novel Pathways in Dystonia Pathogenesis.

Authors:  Genevieve Beauvais; Nicole M Bode; Jaime L Watson; Hsiang Wen; Kevin A Glenn; Hiroyuki Kawano; N Charles Harata; Michelle E Ehrlich; Pedro Gonzalez-Alegre
Journal:  J Neurosci       Date:  2016-10-05       Impact factor: 6.167

4.  Imaging Evidence of Nigrostriatal Degeneration in DYT-PRKRA.

Authors:  Maria João Pinto; Ana Oliveira; Maria José Rosas; João Massano
Journal:  Mov Disord Clin Pract       Date:  2020-04-06

Review 5.  Emerging and converging molecular mechanisms in dystonia.

Authors:  Paulina Gonzalez-Latapi; Nicolas Marotta; Niccolò E Mencacci
Journal:  J Neural Transm (Vienna)       Date:  2021-01-01       Impact factor: 3.575

6.  Functional Genomic Analyses of Mendelian and Sporadic Disease Identify Impaired eIF2α Signaling as a Generalizable Mechanism for Dystonia.

Authors:  Joseph E Rittiner; Zachary F Caffall; Ricardo Hernández-Martinez; Sydney M Sanderson; James L Pearson; Kaylin K Tsukayama; Anna Y Liu; Changrui Xiao; Samantha Tracy; Miranda K Shipman; Patrick Hickey; Julia Johnson; Burton Scott; Mark Stacy; Rachel Saunders-Pullman; Susan Bressman; Kristina Simonyan; Nutan Sharma; Laurie J Ozelius; Elizabeth T Cirulli; Nicole Calakos
Journal:  Neuron       Date:  2016-12-08       Impact factor: 17.173

7.  A truncated PACT protein resulting from a frameshift mutation reported in movement disorder DYT16 triggers caspase activation and apoptosis.

Authors:  Samuel B Burnett; Lauren S Vaughn; Joelle M Strom; Ashley Francois; Rekha C Patel
Journal:  J Cell Biochem       Date:  2019-06-27       Impact factor: 4.429

8.  The HIV protease inhibitor, ritonavir, corrects diverse brain phenotypes across development in mouse model of DYT-TOR1A dystonia.

Authors:  Zachary F Caffall; Bradley J Wilkes; Ricardo Hernández-Martinez; Joseph E Rittiner; Jennifer T Fox; Kanny K Wan; Miranda K Shipman; Steven A Titus; Ya-Qin Zhang; Samarjit Patnaik; Matthew D Hall; Matthew B Boxer; Min Shen; Zhuyin Li; David E Vaillancourt; Nicole Calakos
Journal:  Sci Transl Med       Date:  2021-08-18       Impact factor: 17.956

9.  Opposite actions of two dsRNA-binding proteins PACT and TRBP on RIG-I mediated signaling.

Authors:  Lauren S Vaughn; Evelyn Chukwurah; Rekha C Patel
Journal:  Biochem J       Date:  2021-02-12       Impact factor: 3.857

Review 10.  Combined dystonias: clinical and genetic updates.

Authors:  Anne Weissbach; Gerard Saranza; Aloysius Domingo
Journal:  J Neural Transm (Vienna)       Date:  2020-10-24       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.